(Total Views: 509)
Posted On: 12/30/2020 9:15:37 AM
Post# of 153994
Odd. I thought they just finished enrolling their trial? The article says September. Did they apply before the current trial?
"“The FDA did not agree to grant (emergency use authorisation), as applied for in September,” said Jonathan Javitt, the chief executive officer of U.S.-based NeuroRx"
I assume they are still awaiting results from their current severe/critical trial, so what was their basis for the EUA request back in September?
Should be an interesting day for them, to say the least.
(I have a little spec position, but don't follow it that closely)
"“The FDA did not agree to grant (emergency use authorisation), as applied for in September,” said Jonathan Javitt, the chief executive officer of U.S.-based NeuroRx"
I assume they are still awaiting results from their current severe/critical trial, so what was their basis for the EUA request back in September?
Should be an interesting day for them, to say the least.
(I have a little spec position, but don't follow it that closely)
(0)
(0)
